Black Diamond Therapeutics, Inc. Financial Ratios — BDTX

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-49.87	-58.52	-70.94	-69.67	22.88
Return on Assets (%)	- -	-29.85	-33.56	-27.57	-43.51	-45.14	-52.37	-49.55	16.84
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	18.92
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	16.81
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	28.85
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	28.39
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	140.93
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	31.95
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	31.95
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	31.95
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-49.87	-58.52	-70.94	-69.67	22.88

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	9	28	28	25	22	19
ST Debt	- -	- -	- -	1	- -	3	3	3	4
LT Debt	- -	- -	- -	8	28	25	22	19	15
Total Debt/EBITDA	- -	- -	- -	-0.13	-0.22	-0.3	-0.29	-0.28	0.93
Net Debt/EBITDA	1.92	5.83	5.28	0.5	0.52	0.37	0.65	0.46	-1.04
Total Debt/EBIT	- -	- -	- -	-0.13	-0.22	-0.3	-0.29	-0.28	0.95
Net Debt/EBIT	1.91	5.8	5.27	0.5	0.52	0.37	0.65	0.46	-1.06
EBITDA to Interest Expense	-63	- -	- -	-69,518	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-64.18	- -	- -	-69,660	- -	- -	- -	- -	- -
EBIT to Interest Expense	-63.37	- -	- -	-69,570	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-238.54	-147.25	-29.79	93.35	79.09	74.04	73.62	67.91	78.46
Long-Term Debt/Equity (%)	- -	- -	- -	2.5	14.36	21.87	19	22.55	13.43
Long-Term Debt/Capital (%)	- -	- -	- -	2.43	12.54	17.59	15.62	17.81	11.5
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.33	11.36	16.19	13.99	15.31	10.54
Total Debt/Equity (%)	- -	- -	- -	2.84	14.53	24.32	21.67	26.64	16.74
Total Debt/Capital (%)	- -	- -	- -	2.76	12.68	19.56	17.81	21.04	14.34
Total Debt/Total Assets (%)	- -	- -	- -	2.65	11.49	18.01	15.95	18.09	13.13
Net Debt to Equity	118.02	332.39	327.98	-11.24	-33.59	-29.66	-48.16	-43.75	-18.71
Net Debt/Capital (%)	54.13	76.87	76.63	-12.28	-41.5	-31.33	-65.52	-52.78	-19.08
EBITDA	-4	-9	-29	-70	-127	-92	-86	-78	20
EBITDA-CapEx	-4	-9	-29	-70	-129	-93	-86	-78	20
Operating Income (Loss)	-4	-9	-29	-70	-127	-93	-86	-79	20

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.53	20.06	31.8	22.16	8.87	8.05	6.69	4.79	8.18
Current Ratio	3.55	20.07	32.02	22.48	9.12	8.37	6.82	4.92	8.42
Quick Ratio	3.53	20.06	31.8	22.16	8.87	8.05	6.69	4.79	8.18
CFO/Avg Current Liab	- -	-3.52	-6.63	-5.47	-5.29	-4.37	-3.82	-3.1	1.63
Common Equity/Total Assets	-238.54	-147.25	-29.79	93.35	79.09	74.04	73.62	67.91	78.46
Long-Term Debt/Equity (%)	- -	- -	- -	2.5	14.36	21.87	19	22.55	13.43
Long-Term Debt/Capital (%)	- -	- -	- -	2.43	12.54	17.59	15.62	17.81	11.5
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.33	11.36	16.19	13.99	15.31	10.54
Total Debt/Equity (%)	- -	- -	- -	2.84	14.53	24.32	21.67	26.64	16.74
Total Debt/Capital (%)	- -	- -	- -	2.76	12.68	19.56	17.81	21.04	14.34
Total Debt/Total Assets (%)	- -	- -	- -	2.65	11.49	18.01	15.95	18.09	13.13
CFO/Total Liabilities	-16	-12.55	-12.01	-237.98	-193.4	-209.77	-159.49	-158.31	96.15
CFO/CapEx	-30.53	-111.24	-1,174.95	-367.23	-36.95	-443.14	-2,021.73	- -	- -
Altman's Z-Score	-2.03	0.15	0.08	31.58	0.1	-3.13	-2.54	-5.04	0.08

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,156	193	66	145	121	139
- Cash & Cash Equivalents	8	52	155	35	66	34	56	36	21
+ Preferred Equity and Hybrid Capital	12	61	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	9	28	28	25	22	19
Enterprise Value	5	9	-155	850	12	-29	39	45	29
Total Capital	-7	-16	-47	316	224	144	142	105	131
Total Debt/Capital (%)	- -	- -	- -	2.76	12.68	19.56	17.81	21.04	14.34
Total Debt / EV	- -	- -	- -	0.01	2.41	-0.97	0.65	0.49	0.65
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	0.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	1.43
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	1.46
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	0.98
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	0.98
Diluted Market Cap	- -	- -	- -	1,055	193	65	124	118	140
Diluted Enterprise Value	5	9	-155	1,029	156	59	93	104	138
EV per Share	0.14	0.28	- -	23.56	0.33	- -	0.76	0.79	0.51
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	70
TTM EBITDA	-4	-9	-29	-70	-127	-92	-86	-78	20
TTM Operating Income	-4	-9	-29	-70	-127	-93	-86	-79	20
TTM Cash Flow to Firm	-2	-8	-25	-52	-100	-85	-67	-62	30
TTM Free Cash Flow to Firm	-2	-8	-25	-52	-97	-85	-67	-62	30

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-20.28	-1.98	-0.77	-1.85	-1.89	4.72
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	1.46
Enterprise Value	5	9	-155	850	12	-29	39	45	29
Low Price	- -	- -	- -	17.63	4.89	1.18	1.22	2.08	1.2
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	0.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	1.43
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	6.18
Price/Earnings Average	- -	- -	- -	-16.05	-4.54	-1.08	-1.38	-3.5	6.7
Price/Earnings High	- -	- -	- -	-22.63	-10.88	-2.26	-3.65	-6.05	12.56
Price/Earnings Low	- -	- -	- -	-8.63	-1.41	-0.47	-0.65	-1.64	3.05
Price/Book Value	- -	- -	- -	3.76	0.99	0.57	1.24	1.46	1.24
Price/Book Value Average	- -	- -	- -	3.85	2.91	0.85	1.15	3.01	1.34
Price/Book Value High	- -	- -	- -	5.42	6.98	1.79	3.03	5.21	2.52
Price/Book Value Low	- -	- -	- -	2.07	0.9	0.37	0.54	1.41	0.61
Price/Tangible Book Value	- -	- -	- -	3.76	0.99	0.57	1.24	1.46	1.24
Price/Tangible Book Value Average	- -	- -	- -	3.85	2.91	0.85	1.15	3.01	1.34
Price/Tangible Book Value High	- -	- -	- -	5.42	6.98	1.79	3.03	5.21	2.52
Price/Tangible Book Value Low	- -	- -	- -	2.07	0.9	0.37	0.54	1.41	0.61
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1.97
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	2.14
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	4.01
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	0.97
Price/Cash Flow	- -	- -	- -	-20.23	-1.93	-0.77	-1.85	-1.89	4.67
Price/Cash Flow Average	- -	- -	- -	-20.71	-5.69	-1.16	-1.71	-3.91	5.06
Price/Cash Flow High	- -	- -	- -	-29.19	-13.64	-2.42	-4.51	-6.77	9.49
Price/Cash Flow Low	- -	- -	- -	-11.13	-1.77	-0.5	-0.8	-1.84	2.3
Price/Free Cash Flow Average	- -	- -	- -	-20.76	-5.85	-1.16	-1.71	-3.91	5.12
Price/Free Cash Flow High	- -	- -	- -	-29.27	-14.02	-2.42	-4.52	-6.77	9.6
Price/Free Cash Flow Low	- -	- -	- -	-11.16	-1.82	-0.5	-0.8	-1.84	2.33
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	2.12
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	4
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	0.95
EV/EBITDA Average	-1.12	-1.03	5.28	-16.66	-4.21	-1	-1.2	-3.02	7.35
EV/EBITDA High	-1.12	-1.03	5.28	-23.63	-10.51	-2.17	-3.75	-5.35	13.87
EV/EBITDA Low	-1.12	-1.03	5.28	-8.78	-1.1	-0.4	-0.37	-1.32	3.29
EV/EBIT Average	-1.11	-1.02	5.27	-16.64	-4.2	-1	-1.19	-3	7.47
EV/EBIT High	-1.11	-1.02	5.27	-23.61	-10.49	-2.16	-3.73	-5.33	14.09
EV/EBIT Low	-1.11	-1.02	5.27	-8.77	-1.1	-0.4	-0.37	-1.31	3.34
Last Price	- -	- -	- -	32.05	5.33	1.8	2.81	2.14	2.43
High Price	- -	- -	- -	46.25	37.76	5.68	6.85	7.66	4.94
Enterprise Value Average	5	9	-155	1,158	533	93	103	237	148
Enterprise Value High	5	9	-155	1,643	1,331	201	323	420	280
Enterprise Value Low	5	9	-155	610	140	37	32	104	66

Shares Outstanding	33	33	33	36	36	36	52	57	57
Diluted Weighted Avg Shares	7	14	33	33	36	36	44	55	58
Basic Weighted Avg Shares	7	14	33	33	36	36	44	55	57
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	1.23
EBITDA per Share	-0.57	-0.64	-0.9	-2.11	-3.5	-2.55	-1.96	-1.43	0.36
Operating Income per Share	-0.57	-0.64	-0.9	-2.11	-3.51	-2.56	-1.97	-1.43	0.35
Basic EPS, GAAP	-0.64	-0.64	-1.08	-2.04	-3.47	-2.52	-1.88	-1.27	0.39
Basic EPS from Cont Ops	-0.64	-0.64	-1.08	-2.04	-3.47	-2.52	-1.88	-1.27	0.39
Diluted EPS, GAAP	-0.64	-0.64	-1.08	-2.04	-3.47	-2.52	-1.88	-1.27	0.39
Diluted EPS from Cont Ops	-0.64	-0.64	-1.08	-2.04	-3.47	-2.52	-1.88	-1.27	0.39
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.33	-0.61	-0.76	-1.58	-2.77	-2.35	-1.52	-1.13	0.52
Free Cash Flow per Basic Share	-0.34	-0.61	-0.76	-1.59	-2.84	-2.35	-1.52	-1.13	0.52
Cash & Equivalents per Share	0.24	1.58	4.74	8.73	5.79	3.37	2.54	1.74	2.25
Book Value per Share	-0.59	-2.34	-1.44	8.53	5.41	3.18	2.26	1.47	1.96
Tangible Book Value per Share	-0.59	-2.34	-1.44	8.53	5.41	3.18	2.26	1.47	1.96

Black Diamond Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)